Reply

Affiliations

Comment

Alina Soare et al. Arthritis Rheumatol. 2021 Jan.

. 2021 Jan;73(1):179-180.

doi: 10.1002/art.41467. Epub 2020 Nov 17.

¹ Friedrich-Alexander University Erlangen-Nuremberg and Universitätsklinikum Erlangen, Erlangen, Germany.

No abstract available

Comment on

Dipeptidylpeptidase 4 as a Marker of Activated Fibroblasts and a Potential Target for the Treatment of Fibrosis in Systemic Sclerosis.
Soare A, Györfi HA, Matei AE, Dees C, Rauber S, Wohlfahrt T, Chen CW, Ludolph I, Horch RE, Bäuerle T, von Hörsten S, Mihai C, Distler O, Ramming A, Schett G, Distler JHW. Soare A, et al. Arthritis Rheumatol. 2020 Jan;72(1):137-149. doi: 10.1002/art.41058. Arthritis Rheumatol. 2020. PMID: 31350829
Dipeptidylpeptidase 4 as a Marker of Fibrosis in Systemic Sclerosis: Comment on the Article by Soare et al.
Liebling MR. Liebling MR. Arthritis Rheumatol. 2021 Jan;73(1):178-179. doi: 10.1002/art.41470. Epub 2020 Dec 7. Arthritis Rheumatol. 2021. PMID: 32754964 No abstract available.

1. Suzuki T, Tada Y, Gladson S, Nishimura R, Shimomura I, Karasawa S, et al. Vildagliptin ameliorates pulmonary fibrosis in lipopolysaccharide-induced lung injury by inhibiting endothelial-to-mesenchymal transition. Respir Res 2017;18:177.
1. Kaji K, Yoshiji H, Ikenaka Y, Noguchi R, Aihara Y, Douhara A, et al. Dipeptidyl peptidase-4 inhibitor attenuates hepatic fibrosis via suppression of activated hepatic stellate cell in rats. J Gastroenterol 2014;49:481-91.
1. Wang XM, Holz LE, Chowdhury S, Cordoba SP, Evans KA, Gall MG, et al. The pro-fibrotic role of dipeptidyl peptidase 4 in carbon tetrachloride-induced experimental liver injury. Immunol Cell Biol 2017;95:443-53.
1. Györfi AH, Matei AE, Distler JH. Targeting TGF-β signaling for the treatment of fibrosis [review]. Matrix Biol 2018;68-69:8-27.
1. Distler JH, Györfi AH, Ramanujam M, Whitfield ML, Königshoff M, Lafyatis R. Shared and distinct mechanisms of fibrosis [review]. Nat Rev Rheumatol 2019;15:705-30.